• Users Online: 163
  • Print this page
  • Email this page

Now can be seen on American Academy of Ophthalmology (AAO):

https://www.aao.org/journals
American Academy Ophthalmology

Current Issue

October-December 2019| Vol 9| Issue 4

Editorial

The omnipresence of vascular endothelial growth factor in retinal diseases

[INLINE:1] More than seven decades ago, Michaelson [1] proposed that a diffusible and soluble factor X was responsible for retinal vascular growth during development and pathological states such as...


Review Article

Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?

Prior to the development of panretinal photocoagulation (PRP) in the 1970s, proliferative diabetic retinopathy (PDR) was the most common cause of blindness in diabetic patients. The diabetic retinop...


Review Article

Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment

Diabetic macular edema (DME) is the most common cause of moderate visual loss in diabetic patients. The current treatment of choice for center-involved DME is anti-vascular endothelial growth factor...


Review Article

Corticosteroids for diabetic macular edema

Diabetic macular edema (DME) is a chronic condition with a multifactorial pathogenesis. Vascular endothelial growth factor (VEGF) and several inflammatory mediators are upregulated in eyes with DME....


Original Article

Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population

BACKGROUND/PURPOSE: Age-related macular degeneration (AMD) is the leading cause of visual impairment in patients over 55 years. Currently, the most common therapies for neovascular AMD (nAMD)...


View All Articles in the Current Issue
ISSN - Print: 2211-5056,
Online: 2211-5072

Taiwan Journal of Ophthalmology is the official, peer-reviewed ,Quarterly, open access journal of the Ophthalmological Society of Taiwan (TOS), founded in May 1960 and is committed to active participation in eye care and the promotion of scientific research in ophthalmology.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ, PubMed Central, SCOPUS